Published in Virologie on November 18, 1978
Immunological changes in human skeletal muscle and blood after eccentric exercise and multiple biopsies. J Physiol (2000) 1.63
Cytofluorometric methods for assessing absolute numbers of cell subsets in blood. European Working Group on Clinical Cell Analysis. Cytometry (2000) 1.63
There is a palliative Europe to build/1st Congress of the European Association of Palliative Care. J Palliat Care (1990) 1.39
Alterations in the signal-transducing molecules of T cells and NK cells in colorectal tumor-infiltrating, gut mucosal and peripheral lymphocytes: correlation with the stage of the disease. Int J Cancer (1995) 1.29
Flow cytometric quantitation of immunofluorescence intensity: problems and perspectives. European Working Group on Clinical Cell Analysis. Cytometry (1998) 1.28
Reaction of human smooth muscle antibody with thyroid cells. Clin Exp Immunol (1974) 1.24
Polymorphism of the HLA-D region in American blacks. A DR3 haplotype generated by recombination. J Immunol (1988) 1.19
Intestinal enterokinase. Mechanisms of tts "secretion" into the lumen of the small intestine. Lancet (1971) 1.17
Variability in B-cell antigen expression: implications for the treatment of B-cell lymphomas and leukemias with monoclonal antibodies. Hematol J (2001) 1.05
Serum levels of lymphokines and soluble cellular receptors in primary Epstein-Barr virus infection and in patients with chronic fatigue syndrome. J Infect Dis (1992) 1.02
Correlations between anti-albumin antibodies and HBsAG in hepatic patients. J Med Virol (1977) 1.01
Methods for detection of anti-albumin autoantibodies in hepatic diseases. J Immunol Methods (1977) 1.00
Autoantibodies detected in rabbits hyperimmunized with group A, C, and G streptococcal vaccines. Infect Immun (1977) 0.96
Decreased expression of signal-transducing CD3 zeta chains in T cells from the joints and peripheral blood of rheumatoid arthritis patients. Scand J Immunol (1998) 0.95
Inhibition of activated/memory (CD45RO(+)) T cells by oxidative stress associated with block of NF-kappaB activation. J Immunol (2001) 0.94
Receptors for polymerized albumin on liver cells. Experientia (1977) 0.94
Persistent productive HIV infection in EBV-transformed B lymphocytes. J Med Virol (1989) 0.93
Effects of eccentric exercise on the immune system in men. J Appl Physiol (1985) (1999) 0.92
Immunogenicity of glutaraldehyde-treated homologous albumin in rabbits. Immunochemistry (1978) 0.90
Deeper insight into HBsAg--anti-albumin antibody correlations. J Med Virol (1979) 0.87
DNA immunization with HIV early genes in HIV type 1-infected patients on highly active antiretroviral therapy. AIDS Res Hum Retroviruses (2004) 0.84
Physiological assessment of severe chronic asthma in children. Respiration (1978) 0.84
Morphohistological analysis and histochemistry of Feijoa sellowiana somatic embryogenesis. Protoplasma (2004) 0.83
Autoantibodies to the basal cells of squamous epithelium react with thymic epithelial cells. Clin Immunol Immunopathol (1985) 0.83
Beclomethasone dipropionate aerosol for asthmatic children requiring maintenance oral steroid therapy. Med J Aust (1976) 0.83
Anti-polymerized albumin antibodies-a test for the evaluation of hepatic function in HBs Ag-positive subjects. Virologie (1977) 0.80
Malignant B-cells have receptors for and respond to interleukin-2. Med Oncol Tumor Pharmacother (1986) 0.80
Increases in circulating levels of monocyte-platelet and neutrophil-platelet complexes following hip arthroplasty. Clin Sci (Lond) (2002) 0.80
Autoantibodies against the basal cell layer: an association with chronic hepatitis B. Clin Immunol Immunopathol (1983) 0.79
Clinical and immunological benefits from highly active antiretroviral therapy in spite of limited viral load reduction in HIV type 1 infection. AIDS Res Hum Retroviruses (2001) 0.79
Autoantibodies to thymic epithelial cells in hepatitis B virus-associated delta infection. J Infect Dis (1985) 0.79
Specificity of anti-albumin autoantibodies in liver diseases. Mol Immunol (1981) 0.79
Immunogenicity of glutaraldehyde treated homologous monomeric albumin in rabbits. Immunochemistry (1978) 0.78
A new antigen/antibody system--the polymerized albumin and antialbumin antibodies. Med Interne (1980) 0.78
Sequence of an HLA-B56 variant (B*5604) identified in the Korean population. Tissue Antigens (1998) 0.77
Urinary excretion of albumin and beta 2-microglobulin in a population from an area where Balkan nephropathy is endemic. Scand J Clin Lab Invest (1977) 0.77
Analysis of HLA-A and -B serologic typing of bone marrow registry donors using polymerase chain reaction with sequence-specific oligonucleotide probes and DNA sequencing. Tissue Antigens (1997) 0.77
[Predictive factors of resistance to treatment of neuropathic pain]. Schweiz Med Wochenschr (1994) 0.77
The DR3(w18),DQw4 haplotype differs from DR3(w17),DQw2 haplotypes at multiple class II loci. Hum Immunol (1989) 0.77
Peripheral blood lymphocyte subsets in patients with chronic hepatitis C--effects of interferon treatment. Liver (1992) 0.76
Seventeen more novel HLA-A locus alleles. Tissue Antigens (2000) 0.76
Radioimmunoassay of anti-albumin autoantibodies in human sera. J Immunol Methods (1981) 0.76
Novel HLA-A locus alleles including A*01012, A*0306, A*0308, A*2616, A*2617, A*3009, A*3206, A*3403, A*3602 and A*6604. Tissue Antigens (2002) 0.76
Differences in peptide binding of DR11 and DR13 microvariants demonstrate the power of minor variation in generating DR functional diversity. Hum Immunol (1995) 0.76
Anti-albumin antibodies in chronic liver diseases: diagnostic significance of these antibodies in patients with conventional or immunosuppressive therapy. Clin Exp Immunol (1981) 0.75
DRB3 alleles with variations in the annealing sites of commonly used amplification primers. Tissue Antigens (2000) 0.75
ABO blood group and sex distribution in anti-HBs-positive subjects. Virologie (1981) 0.75
Diversity and evolution of the DRB1*03 family: description of DRB1*03022,*0307,*0308. Tissue Antigens (1997) 0.75
Viral and rickettsial etiology of an outbreak of acute respiratory tract infection. Virologie (1985) 0.75
The hepatitis E virus. Rom J Virol (1998) 0.75
Reaction spectrum of anti-HBe and AB0 blood groups. Virologie (1983) 0.75
Reaction spectrum of HBe antibodies. Virologie (1982) 0.75
Novel HLA-B alleles, B*8201, B*3515 and B*5106, add to the complexity of serologic identification of HLA types. Tissue Antigens (1996) 0.75
Identification of a new allele, DRB1*1204, during routine PCR-SSOP typing of National Marrow Donor Program volunteers. Tissue Antigens (1996) 0.75
Influenza vaccination by nasal route in a semi-closed community. Virologie (1980) 0.75
Dynamics of neutralizing secretory influenza antibodies after nasal administration of the NIVGRIP trivalent influenza vaccine. Virologie (1985) 0.75
Characterization of an HLA-B62 variant (B*1538) exhibiting an additional B52 serologic reactivity. Tissue Antigens (1997) 0.75
Bivalent influenza vaccination with inactivated vaccines administered by nasal or oral route. Virologie (1976) 0.75
Cellular crossreactivity. Implications for solid organ transplantation matching. Transplantation (1996) 0.75
Novel alleles HLA-B*7802 and B*51022: evidence for convergency in the HLA-B5 family. Tissue Antigens (1996) 0.75
Apparently healthy HBsAg carriers: sex-dependent difference in ABO blood group distribution, subtype ratio and antigen titer. Virologie (1978) 0.75
Immune precipitation phenomena observed between serum samples from healthy subjects. Virologie (1983) 0.75
[Treatment with ACTH in the myasthenic syndrome with an immunological substratum]. Neurol Psihiatr Neurochir (1974) 0.75
[The humoral and cell-mediated immune response induced by the NIVGRIP inactivated influenza vaccine]. Virologie (1989) 0.75
Nonrandom T cell receptor usage in the allorecognition of HLA-DR1 microvariation. J Immunol (1993) 0.75
ABO blood groups and HBs AG subtypes and titers in healthy carriers. Vox Sang (1977) 0.75
A description of a new DR allele, DRB1*1113. Tissue Antigens (1995) 0.75
Apparently healthy HBs antigen carriers: ABO blood group distribution and ay : ad ratio. Virologie (1977) 0.75
Investigations on HBe antigen. Note II. Dynamics of HBsAg in acute viral hepatitis, according to HBeAg persistence or seroconversion. Virologie (1982) 0.75
Investigations of HBe antigen. Note I. Prevalence of HBeAg and anti-HBe in the stationary phase of HBsAg-positive acute viral hepatitis. Virologie (1981) 0.75
Incidence of hepatitis B surface antigen (HBsAg) in some areas of Romania. Virologie (1977) 0.75
[The possibility of the vertical intrapartum transmission of the HIV and HB viruses]. Rev Roum Virol (1993) 0.75
Clarification of HLA-B serologically ambiguous types by automated DNA sequencing. Tissue Antigens (1998) 0.75
Assessing obstructive airways disease in children. Which test is best? Aust Paediatr J (1976) 0.75
Investigations on HBe antigen. Note III. HBe system and sex-dependent clearance of HBsAg subtypes. Virologie (1982) 0.75
Reaction spectrum of anti-HBe and ABO blood groups. Virologie (1982) 0.75
[Terminal dyspnea: morphine may be useful]. Schweiz Rundsch Med Prax (1992) 0.75
DR and DQ beta cDNA sequences associated with a DR2 haplotype. Hum Immunol (1988) 0.75
[Hepatitis C viral infection. II. Viral morphology not yet determined]. Bacteriol Virusol Parazitol Epidemiol (1997) 0.75
Preliminary data on the prevalence of anti-delta in Romania. Virologie (1986) 0.75
Relationship of DR3 T cell recognition determinants to DNA sequence. Transplant Proc (1989) 0.75
Visual-field measurements and driving eligibility. J Am Optom Assoc (1997) 0.75
The relationship between HLA-B45 and B* 5002 in the five major U.S. population groups. Tissue Antigens (2000) 0.75
Viral hepatitis and ABO blood groups. Virologie (1976) 0.75
Immunofluorescence study on the prevalence of some respiratory viruses in subjects vaccinated against influenza and in unvaccinated controls. Virologie (1986) 0.75
Morbidity by upper respiratory tract diseases in a semi-closed community, after intranasal application of an inactivated influenza vaccine. Virologie (1982) 0.75
[The incidence of viral and microbial antigens and the serum interferon titer in certain forms of rheumatism]. Rev Roum Virol (1992) 0.75
Twelve novel HLA-B*15 alleles carrying previously observed sequence motifs are placed into B*15 subgroups. Tissue Antigens (2001) 0.75
[Dynamics of interferon in the rhinopharyngeal secretions of adults vaccinated with the NIVGRIP inactivated influenza vaccine by the nasal route]. Virologie (1986) 0.75
DQ polymorphism: an analysis of DQw4 alpha and beta membrane proximal regions. Hum Immunol (1990) 0.75
Some immunological features in asymptomatic HBsAg carriers. Virologie (1978) 0.75
New aspects of viral hepatitis plurietiology. Virologie (1983) 0.75
Beclomethasone dipropionate--its effect on airways resistance in children with severe asthma. Postgrad Med J (1975) 0.75
Novel HLA-A and HLA-B alleles. Tissue Antigens (1998) 0.75
Recent research on viral hepatitis performed in the "Stefan S. Nicolau" Institute of Virology. Virologie (1985) 0.75
The hepatitis E virus. Rev Roum Virol (1994) 0.75
Red cell agglutination for HBsAg detection. Virologie (1978) 0.75